• FDA accepts new drug application for Tavalisse to treat immune thrombocytopenia

    4 monthes ago - By Healio

    The FDA accepted the new drug application for fostamatinib disodium, an oral investigational drug candidate in development to treat patients with chronic or persistent immune thrombocytopenia.Fostamatinib disodium is designed to inhibit the spleen tyrosine kinase.
    Read more ...

     

  • FDA accepts supplemental application for Xgeva to treat patients with multiple myeloma

    4 monthes ago - By Healio

    The FDA accepted a supplemental biologics application that seeks to expand the approval of denosumab to include patients with multiple myeloma, according to the drug's manufacturer.Denosumab is the first fully human monoclonal antibody that binds to and neutralizes RANK ligand, a protein that is vital for the formation, function and survival of osteoclasts.
    Read more ...